482
Views
5
CrossRef citations to date
0
Altmetric
Clinical Study

High Prevalence of Risk Factors for Chronic Kidney Disease in Balkan Endemic Nephropathy Foci

, , , , , , , , , & show all
Pages 467-471 | Received 26 Oct 2011, Accepted 09 Jan 2012, Published online: 24 Feb 2012

REFERENCES

  • Gaon J. Endemic Nephropathy in Bosnia. In: Wolstenholme GEW, Knight J, eds. The Balkan Nephropathy. London: Ciba Foundation Study Group No 30; 1967:51–57.
  • Čavaljuga S, Ibrahimović L. Epidemiology of endemic nephropathy in Bosnia and Herzegovina until 1990—A tribute to the late Professor Jacob A. Gaon HealthMED. 2010;4(Suppl. 1):200–209.
  • Gaon J, Dedić I, Telebak B, Turić A. Occurrence of endemic nephropathy in SR B&H. In: Strahinjić S, Stefanović V, eds. Current Research in Endemic (Balkan) Nephropathy. Proceedings of the 5th Symposium. Niš: University Press; 1983:263–267.
  • Fajgelj A, Dedić I, Janković D, . Medical geography of endemic nephropathy in Bosnia and Herzegovina [in Serbian]. In: Petković S, ed. Proceedings of the 3rd Symposium on Endemic nephropathy, Belgrade 1982. Belgrade: SANU–Scientific meetings, Department of Medical Science; 1982:29–41.
  • Stengel B, Billon S, van Dijk PC, . Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990–1999. Nephrol Dial Transplant. 2003;18:1824–1833.
  • Lysaght MJ. Maintenance dialysis population dynamics: Current trends and long-term implications. J Am Soc Nephrol. 2002;13:S37–S40.
  • El Nahas AM, Bello AK. Chronic kidney disease: The global challenge. Lancet. 2005;365:331–340.
  • The Renal Register for Bosnia and Herzegovina. Available at: http://www.undt.ba/index.php?option=com_content&view=article&id=61&Itemid=92&lang=en. Accessed January 26, 2012.
  • Mesic E, Resic H, Halilbasic A, . Renal replacement therapy in Bosnia and Herzegovina: Report of the Society of Nephrology, Dialysis and Transplantation of Bosnia and Herzegovina. Nephrol Dial Transplant. 2003;18:661–663.
  • Chadban SJ, Briganti EM, Kerr PG, . Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol. 2003;14(Suppl. 2):S131–S138.
  • Coresh J, Selvin E, Stevens LA, . Prevalence of chronic kidney disease in the United States. J Am Med Assoc. 2007;298:2038–2047.
  • de Jong PE, van der Velde M, Gansevoort RT, Zoccali C. Screening for chronic kidney disease: Where does Europe go? Clin J Am Soc Nephrol. 2008;3:616–623.
  • Cukuranovic R, Petrovic B, Cukuranovic Z, Stefanović V. Balkan endemic nephropathy: A decreasing incidence of the disease. Pathol Biol (Paris). 2000;48:558–561.
  • Dimitrov PS, Simeonov VA, Ganev VS, Karmaus WJ. Is the incidence of Balkan endemic nephropathy decreasing? Pathol Biol (Paris). 2002;50:38–41.
  • Bukvic D, Maric I, Arsenovic A, Jankovic S, Djukanovic L. Prevalence of Balkan endemic nephropathy has not changed since 1971 in the Kolubara region in Serbia. Kidney Blood Press Res. 2007;30:117–123.
  • Janković S, Bukvić D, Marinković J, Janković J, Marić I, Djukanović L. Time trends in Balkan endemic nephropathy incidence in the most affected region in Serbia, 1977–2009: The disease has not yet disappeared. Nephrol Dial Transplant. 2011;26:2171–2176.
  • Manns B, Hemmelgarn B, Tonelli M, . Alberta Kidney Disease Network: Population based screening for chronic kidney disease: cost effectiveness study. BMJ. 2010;341:c5869.
  • Vukušić Z, Strahinjić S, Stevčić M, . Contribution to investigation of arterial hypertension mechanisms in patients with endemic nephropathy [in Serbian]. Proceedings of the III Symposium of Endemic Nephropathy, Niš 1975. Beograd: Documenta Galenika; 1977:320–326.
  • Mešić E. Early detection of Balkan endemic nephropathy in Bosanska Posavina. Bos J Bas Med Sci. 2010;10(Suppl. 1):S83–S90.
  • Pecin I, Miletić-Medved M, Jovanović A, . Prevalence, treatment and control of hypertension in a Croatian focus of EN comparison with epidemiology of hypertension (EHUH) study results. Coll Antropol. 2006;30(Suppl. 1):55–59.
  • Jakovljević D, Bjeloglav D. Zdravstveno Stanje, Zdravstvene Potrebe I Korišćenje Zdravstvene Zaštite Stanovništva U Republici Srpskoj. Banjaluka: EPOS Health Consultants; 2003.
  • Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet. 2005;365:217–223.
  • Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053.
  • Istraživanje riziko faktora nezaraznih bolesti u Federaciji Bosne i Hercegovine 2002. Sarajevo-Mostar: Zavod za javno zdravstvo FBiH; 2002.
  • Raičević S, Trnacević S, Hranisavljević J, Vučelić D. Renal function, protein excretion, and pathology of Balkan endemic nephropathy. II. Protein excretion. Kidney Int Suppl. 1991;34:S52–S56.
  • Danilović V. Endemic nephropathy in Yugoslavia. In: Strahinjic S, Stefanović V, eds. Endemic (Balkan) Nephropathy. Proceedings of the 4th Symposium, Nis 1979. Nis: Institute of Nephrology Hemodialysis; 1981:1–5.
  • Dimitrov P, Tsolova S, Georgieva R, . Clinical markers in adult offspring of families with and without Balkan endemic nephropathy. Kidney Int. 2006;69:723–729.
  • Stefanović V, Mitic-Zlatkovic M, Cukuranovic R, Vlahovic P. Increased urinary protein excretion in children from families with Balkan endemic nephropathy. Nephron Clin Pract. 2003;95:c116–c120.
  • Hrisoho D, Zafirovska K, Bogdanovska S, Medar T. Prevalence of endemic nephropathy in SAP Kosovo [in Serbian]. In: Petković S, ed. Proceedings of 3rd Symposium on Endemic Nephropathy, Belgrade 1982. Belgrade: SANU—Scientific meetings; 1982:60–65.
  • Stefanović V, Jelaković B, Čukuranović R, . Diagnostic criteria for Balkan endemic nephropathy: Proposal by an international panel. Ren Fail. 2007;29:867–880.
  • Djukanović Lj, Marinković J, Marić I, . Contribution to the definition of diagnostic criteria for Balkan endemic nephropathy. Nephrol Dial Transplant. 2008;23:3932–3938.
  • Król E, Rutkowski B, Czarniak P, . Early detection of chronic kidney disease: Results of the PolNef study. Am J Nephrol. 2009;29:264–273.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.